Pfizer’s and Lilly’s JAK inhibitor safety concerns prompt Europe to scrutinize drug class
Pfizer’s and Lilly’s JAK inhibitor safety concerns prompt Europe to [...]
Pfizer’s and Lilly’s JAK inhibitor safety concerns prompt Europe to [...]
Pfizer stalls COVID-19 vaccine app as it awaits data on [...]
FDA sets an example through Eli Lilly, Innovent’s PD-1, rocking [...]
Ipsen telegraphs $400M deal for consumer healthcare split fkansteiner Fri, [...]
Lilly back in COVID-19 antibody game with $720 million deal [...]
Eli Lilly promises 40% discount for Innovent’s PD-1 in last-ditch [...]
FDA nominee Califf pledges to enforce accelerated approval mandates as [...]
AstraZeneca’s COVID vaccine sales reached $4B last year, but don’t [...]
GlaxoSmithKline’s COVID-19 antibody delivers as Nucala, Trelegy eclipse £1B landmark [...]
Teva banks on blockbuster Austedo sales as COVID-19, Copaxone generics [...]